Skip to content

Strategy + RehaCom for Memory Rehabilitation in Traumatic Brain Injury (TBI)

RehaCom Memory Modules in Moderate-to-severe Traumatic Brain Injury (TBI)

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04239456
Acronym
REHACOM-NJHF
Enrollment
20
Registered
2020-01-27
Start date
2018-12-01
Completion date
2022-11-28
Last updated
2022-03-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Traumatic Brain Injury With Loss of Consciousness

Keywords

TBI, Face memory, Verbal Memory, Learning, Cognition, Memory training, Pilot study, compensatory memory strategies, cognitive rehabilitation

Brief summary

The purpose of this research study is to evaluate the effectiveness of RehaCom, a computerized treatment for memory deficits, in a 16-session, interactive course. Following a manualized approach, the Rehacom modules will be used for the repeated application of the content acquired during 1-on-1 memory strategy training. The goal is to improve face/name, list and verbal memory of patients who survived a moderate to severe traumatic brain injury.

Detailed description

This randomized clinical trial (RCT) consists of 20 chronic moderate-to-severe TBI patients who will receive memory strategy training and complete three memory modules of the RehaCom at one of the Kessler Foundation locations. Changes in attention, processing speed, verbal/non-verbal new learning and memory (NLM) and executive control will be assessed via pre/post and 3-month follow-up assessments before and after the 8-10 week intervention. Self-report questionnaires will also track functional and emotional outcomes such as mood and anxiety, cognition, quality of life, self-efficacy, deficit awareness, community participation, and readiness for occupational functioning

Interventions

DEVICERehaCom (software)

RehaCom software has gamified, interactive modules that will help participants practice the application of various memory strategies at custom, increasingly more difficult levels. Instructor will also use the software to teach and demonstrate the use of memory strategies with the domains targeted (i.e., list learning, remembering written/verbal information, and memory for names/faces).

Sponsors

New Jersey Medical School
CollaboratorOTHER
Kessler Foundation
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Masking description

Group assignments will be concealed and assessments and interventions will be conducted by trained staff blinded to each other's findings and data.

Intervention model description

This study is a double-blind randomized clinical trial. Participants will be randomly assigned to a treatment group or wait-list control group.

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Able to read and speak English fluently at the 5th grade level (for testing; software has multilingual support) * Had a TBI at least 1 year ago * No history of learning disorders during school years * Able to use a personal computer (PC) non-stop for 1 hour without health or visual complaints; able to press keyboard buttons.No history of learning disorders

Exclusion criteria

* Actively participating in another intervention study * Distance to Kessler Foundation East Hanover or West Orange location is more than 20 miles.

Design outcomes

Primary

MeasureTime frameDescription
Change in California Verbal Learning Test - II (CVLT-II) performanceBaseline & 10-14 weeks after baseline assessmentWe will use the raw scores for free and cued delayed recall \[0-16\] where higher scores indicate better verbal recall.
Change in the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) - Story Memory performancebaseline & 10-14 weeks after baseline assessmentRaw scores from Story A and Story B recall \[0-50\], where higher scores indicate better recall.
Change in Wechsler Memory Scale III - Faces II performancebaseline & 10-14 weeks after baseline assessmentDelayed Recall Score \[0-48\] where higher scores indicate better recall.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026